These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38583785)

  • 21. Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide.
    Htet TD; Eisman JA; Elder GJ; Center JR
    Osteoporos Int; 2018 Feb; 29(2):517-518. PubMed ID: 29247298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblast as a target of anti-osteoporotic treatment.
    Corrado A; Sanpaolo ER; Di Bello S; Cantatore FP
    Postgrad Med; 2017 Nov; 129(8):858-865. PubMed ID: 28770650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analysis From the ACTIVE Phase 3 Trial.
    Cosman F; Peterson LR; Towler DA; Mitlak B; Wang Y; Cummings SR
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3384-95. PubMed ID: 32658264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the Efficacy and Safety of Teriparatide and Alendronate in the Treatment of Osteoporosis After Renal Transplantation.
    Qiu Z; Lin C; Zhang Y; Lin C; Deng J; Wu M
    Iran J Kidney Dis; 2021 Dec; 15(6):451-456. PubMed ID: 34930857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and Safety of Teriparatide in Beta-Thalassemia Major Associated Osteoporosis: A Real-Life Experience.
    Gagliardi I; Celico M; Gamberini MR; Pontrelli M; Fortini M; Carnevale A; Napoli N; Zatelli MC; Ambrosio MR
    Calcif Tissue Int; 2022 Jul; 111(1):56-65. PubMed ID: 35243531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect and role of teriparatide in the treatment of osteoporosis].
    Nakamura T
    Clin Calcium; 2012 Mar; 22(3):309-14. PubMed ID: 22370296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anabolic skeletal therapy for osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):745-54. PubMed ID: 17117299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of anti-osteoporosis medications in preventing vertebral body fractures after balloon kyphoplasty.
    Ueno M; Tajima Y; Ito S; Tsuji M; Toriumi E; Yoshii A; Otake N; Tanaka H
    Arch Osteoporos; 2024 Mar; 19(1):19. PubMed ID: 38512565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Updates on Lifestyle-Related Diseases and Bone Metabolism. Teriparatide for osteoporosis associated with lifestyle-related diseases].
    Fukumoto S
    Clin Calcium; 2014 Nov; 24(11):1701-5. PubMed ID: 25355155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis.
    Tashjian AH; Gagel RF
    J Bone Miner Res; 2006 Mar; 21(3):354-65. PubMed ID: 16491282
    [No Abstract]   [Full Text] [Related]  

  • 31. Systematical Mutational Analysis of FRATtide against Osteoclast Differentiation by Alanine Scanning.
    Yang Y; Geng C; Shen H; Chao J; Wang Z; Cong W; Li X; Ye G; Jiang Y
    ACS Med Chem Lett; 2024 Aug; 15(8):1242-1249. PubMed ID: 39140067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.
    Leder BZ; Tsai JN; Uihlein AV; Wallace PM; Lee H; Neer RM; Burnett-Bowie SA
    Lancet; 2015 Sep; 386(9999):1147-55. PubMed ID: 26144908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anabolic therapy for osteoporosis.
    Bilezikian JP
    Int J Fertil Womens Med; 2005; 50(2):53-60. PubMed ID: 16334411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of parathyroid hormone in the treatment of osteoporosis.
    Girotra M; Rubin MR; Bilezikian JP
    Rev Endocr Metab Disord; 2006 Jun; 7(1-2):113-21. PubMed ID: 17043762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.
    Nishikawa A; Ishida T; Taketsuna M; Yoshiki F; Enomoto H
    Clin Interv Aging; 2016; 11():913-25. PubMed ID: 27462147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05.
    Mori S; Hagino H; Sugimoto T; Tanaka S; Mitomo Y; Takahashi K; Sone T; Nakamura T; Soen S
    Osteoporos Int; 2023 Jan; 34(1):189-199. PubMed ID: 36239756
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The teriparatide in the treatment of severe senile osteoporosis.
    Manuele S; Sorbello L; Puglisi N; Grasso S; La Malfa L; D'Urbino G; Rizzotto M; Strano S; Maugeri D
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():249-58. PubMed ID: 17317460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistence with teriparatide in patients with osteoporosis: the UK experience.
    Arden NK; Earl S; Fisher DJ; Cooper C; Carruthers S; Goater M
    Osteoporos Int; 2006; 17(11):1626-9. PubMed ID: 16823543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biologicals in osteoporosis: teriparatide and parathyroid hormone in women and men.
    Devogelaer JP; Boutsen Y; Manicourt DH
    Curr Osteoporos Rep; 2010 Sep; 8(3):154-61. PubMed ID: 20563900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status.
    Langdahl BL; Marin F; Shane E; Dobnig H; Zanchetta JR; Maricic M; Krohn K; See K; Warner MR
    Osteoporos Int; 2009 Dec; 20(12):2095-104. PubMed ID: 19350340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.